Detection and identification of SARS-CoV-2 and Influenza A based on microfluidic technology

Yujie Liu,Guanliu Yu,Hongkun Liang,Wenbo Sun,Lulu Zhang,Michael Mauk,Hua Li,Lei Chen
DOI: https://doi.org/10.1039/d4ay00847b
IF: 3.1
2024-06-20
Analytical Methods
Abstract:As of now, the global COVID-19 pandemic caused by SARS-CoV-2, which began in 2019, has been effectively controlled. However, the symptoms of influenza A virus infection were similar to those of SARS-CoV-2 infection, but they required different treatment approaches. To make the detection more accurate and the treatment more targeted. We developed a system that integrates RPA and CRISPR assays, allowing for the rapid, highly specific, and sensitive detection and differentiation of SARS-CoV-2, H1N1, and H3N2. Under isothermal amplification conditions, the RPA-CRISPR Cas12a detection system achieved a detection limit as low as 5 copies/μL, demonstrating excellent specificity. The measurement time was approximately 30 minutes. The RPA-CRISPR Cas12a detection system combined with the microfluidic system we designed to simultaneously detect three viruses, providing a potential solution for efficient and reliable diagnosis.
spectroscopy,chemistry, analytical,food science & technology
What problem does this paper attempt to address?